340 related articles for article (PubMed ID: 19427967)
1. Association studies of CYP1A1 and GSTM1 polymorphisms with esophageal cancer risk: evidence-based meta-analyses.
Zhuo WL; Zhang YS; Wang Y; Zhuo XL; Zhu B; Cai L; Chen ZT
Arch Med Res; 2009 Apr; 40(3):169-79. PubMed ID: 19427967
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between CYP1A1, GSTM1 genetic polymorphisms and susceptibility to esophageal squamous cell carcinoma].
Shao G; Su Y; Huang G; Wen B
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):420-3. PubMed ID: 11860825
[TBL] [Abstract][Full Text] [Related]
3. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
[TBL] [Abstract][Full Text] [Related]
4. [Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer].
Fan CH; Jin MJ; Zhang Y; Song L; Xu H; Jiang QT; Yu WP; Chen K
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):13-7. PubMed ID: 16620591
[TBL] [Abstract][Full Text] [Related]
5. [Meta-analysis on glutathione S-transferase M1 polymorphisms and the risk of esophageal cancer].
Huang ZG
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Oct; 25(10):898-901. PubMed ID: 15631753
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of CYP1A1 and GSTM1 and lung cancer risk.
Gsur A; Haidinger G; Hollaus P; Herbacek I; Madersbacher S; Trieb K; Pridun N; Mohn-Staudner A; Vetter N; Vutuc C; Micksche M
Anticancer Res; 2001; 21(3C):2237-42. PubMed ID: 11501853
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of GSTM1 and CYP1A1 genes and their genetic susceptibility to prostate cancer in Chinese men.
Li M; Guan TY; Li Y; Na YQ
Chin Med J (Engl); 2008 Feb; 121(4):305-8. PubMed ID: 18304461
[TBL] [Abstract][Full Text] [Related]
8. Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people.
Acevedo C; Opazo JL; Huidobro C; Cabezas J; Iturrieta J; Quiñones Sepúlveda L
Prostate; 2003 Oct; 57(2):111-7. PubMed ID: 12949934
[TBL] [Abstract][Full Text] [Related]
9. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in the cytochrome P450 1A1, glutathione S-transferase M1 and T1, and susceptibility to colon cancer.
Ye Z; Parry JM
Teratog Carcinog Mutagen; 2002; 22(5):385-92. PubMed ID: 12210502
[TBL] [Abstract][Full Text] [Related]
11. Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection.
Joseph T; Chacko P; Wesley R; Jayaprakash PG; James FV; Pillai MR
Gynecol Oncol; 2006 Jun; 101(3):411-7. PubMed ID: 16360200
[TBL] [Abstract][Full Text] [Related]
12. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
13. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
[TBL] [Abstract][Full Text] [Related]
14. [Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility].
González A; Ramírez V; Cuenca P; Sierra R
Rev Biol Trop; 2004 Sep; 52(3):591-600. PubMed ID: 17361553
[TBL] [Abstract][Full Text] [Related]
15. Combination of TNF-RII, CYP1A1 and GSTM1 polymorphisms and the risk of Japanese SLE: findings from the KYSS study.
Horiuchi T; Washio M; Kiyohara C; Tsukamoto H; Tada Y; Asami T; Ide S; Kobashi G; Takahashi H;
Rheumatology (Oxford); 2009 Sep; 48(9):1045-9. PubMed ID: 19561157
[TBL] [Abstract][Full Text] [Related]
16. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.
Zhuo XL; Li Q; Zhou Y; Cai L; Xiang ZL; Yuan W; Zhang XY
Arch Med Res; 2009 Oct; 40(7):625-34. PubMed ID: 20082880
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of CYP1A1 and GSTM1 and laryngeal cancer risk: evidence-based meta-analyses.
Zhuo WL; Wang Y; Zhuo XL; Zhu B; Zhu Y; Chen ZT
J Cancer Res Clin Oncol; 2009 Aug; 135(8):1081-90. PubMed ID: 19252926
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
[TBL] [Abstract][Full Text] [Related]
19. Association Studies of CYP1A1 Exon7 Polymorphism and -GSTM1 Interaction with Esophageal Cancer Risk: a Meta-Analysis in the Chinese Population.
Chen XP; Xu DF; Xu WH; Ma ZC; Yao J; Fu SM
Clin Lab; 2016 Sep; 62(9):1795-1802. PubMed ID: 28164573
[TBL] [Abstract][Full Text] [Related]
20. [Polymorphism of metabolic gene and genetic susceptibility to prostate cancer].
Guan TY; Li M; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1467-70. PubMed ID: 16318816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
